ALFA Finder| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 0.1 | 0.1 | 0.1 |
| Other income | 0.5 | 0.5 | 0.5 |
| Total income | 0.6 | 0.6 | 0.6 |
| Profit before exceptional items & tax | 0.2 | 0.1 | 0.2 |
| Profit before tax | 0.2 | 0.1 | 0.2 |
| Net profit | 0.1 | 0.0 | 0.2 |
| Operating margin | 33.3% | 16.7% | 33.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -50.00% |
|---|---|
| Revenue, year on year | +0.00% |
| Operating profit, quarter on quarter | +25.00% |
BSE results filing, NSE: EMMESSA. Figures extracted from the filing.
Emmessar Biotech & Nutrition Ltd: key numbers
- Share price
- ₹24.02
- Market cap
- ₹12.00 Cr
- Revenue (annual)
- ₹0.37 Cr
- Net profit (annual)
- ₹0.44 Cr
- P/E (TTM)
- 28.4×Sector 54.5×
- Promoter holding
- 59.53%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emmessar Biotech & Nutrition Ltd
All →Emmessar Biotech & Nutrition Q2 FY27 Results: Net Profit ₹0.1 Cr, Up 0.0% YoY
Emmessar Biotech & Nutrition Ltd's board approved unaudited Q2 FY27 results for the quarter ended 30 September 2026. Net profit after tax was Rs 14.03 lakhs for the quarter, with total income of Rs 62.50 lakhs.
- Key figure
- Net profit ₹0.1 Cr · +0.0% YoY
Emmessar Biotech & Nutrition Board Meeting Date
Emmessar Biotech & Nutrition scheduled a board meeting for 31 October 2026 to consider unaudited quarterly results ended 30 September 2026. The trading window stays closed until 02 November 2026.
Emmessar Biotech & Nutrition Other Announcement
Emmessar Biotech & Nutrition Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with regulatory reporting standards.
Emmessar Biotech & Nutrition Annual General Meeting
Emmessar Biotech & Nutrition Ltd conducted its 34th Annual General Meeting on September 29, 2026. Key business included adopting financial statements and re-appointing directors.
Emmessar Biotech & Nutrition Other Announcement
Emmessar Biotech & Nutrition informed shareholders without registered email addresses about accessing the Annual Report and 34th AGM Notice via the company's website.
Emmessar Biotech & Nutrition Annual General Meeting
Emmessar Biotech & Nutrition Limited has issued a notice for its 34th Annual General Meeting, scheduled to be held on September 29, 2026, via video conferencing.